Cystic Fibrosis

Top Story

Oral therapy as safe, effective as insulin in cystic fibrosis-related diabetes

December 7, 2017
In the Journals

Orkambi yields positive results in younger patients with cystic fibrosis

June 12, 2017
Orkambi improved lung function in patients 6 to 11 years old with cystic fibrosis within 15 days of treatment, according to phase 3 trial results recently published in…
FDA News

FDA expands approval of Kalydeco to include additional cystic fibrosis mutations

May 18, 2017
The FDA has extended approval for ivacaftor to treat 23 additional mutations of cystic fibrosis among pediatric patients aged older than 2 years. Previously, ivacaftor…
In the Journals

Patients with cystic fibrosis live nearly 10 years longer in Canada than US

March 13, 2017
Compared with American patients with cystic fibrosis, Canadians with the disorder have a significant survival advantage, most likely due to differences in health care…
More Headlines »
Feature Article

Manifestations of Food Allergy in Infants and Children

Pediatric Annals, August 2008, Volume 37 Issue 8
Parents frequently report that their children have adverse reactions to foods. Pediatricians must be familiar with the…
More »
Video Perspective

VIDEO: AHCA still faces 'uphill battle' in Senate, speaker says

May 4, 2017
More »